This table lists the drugs in the Reference Drug Program (RDP) and, for each drug, indicates if the drug is eligible for full or partial coverage.
Medical evidence shows that drugs within each therapeutic category are equally safe and effective.
Partial coverage indicates the non-reference drug will be covered up to a maximum amount based on the cost of the reference drug(s) in the category, which are the most cost-effective.
RDP Category | Drug name (chemical name) | RDP Coverage status | Requires Special Authority for full coverage? (Click "Yes" for criteria and forms) |
---|---|---|---|
Angiotensin converting enzyme inhibitors (ACEIs) | benazepril | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | captopril | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | cilazapril with/without HCTZ | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | enalapril with/without HCTZ | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | fosinopril | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | lisinopril with/without HCTZ | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | perindopril | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | quinapril with/without HCTZ | Partially covered | Yes |
Angiotensin converting enzyme inhibitors (ACEIs) | ramipril with/without HCTZ | Fully covered | No |
Angiotensin converting enzyme inhibitors (ACEIs) | trandolapril | Partially covered | Yes |
Angiotensin receptor blockers (ARBs) | candesartan with/without HCTZ | Fully covered | Yes |
Angiotensin receptor blockers (ARBs) | eprosartan with/without HCTZ | Partially covered | Yes |
Angiotensin receptor blockers (ARBs) | irbesartan with/without HCTZ | Partially covered | Yes |
Angiotensin receptor blockers (ARBs) | losartan with/without HCTZ | Fully covered | Yes |
Angiotensin receptor blockers (ARBs) | olmesartan with/without HCTZ | Partially covered | Yes |
Angiotensin receptor blockers (ARBs) | telmisartan with/without HCTZ or amlodipine | Fully covered | Yes |
Angiotensin receptor blockers (ARBs) | valsartan with/without HCTZ | Fully covered | Yes |
Dihydropyridine calcium channel blockers (CCBs) | amlodipine | Fully covered | No |
Dihydropyridine calcium channel blockers (CCBs) | felodipine | Partially covered | Yes |
Dihydropyridine calcium channel blockers (CCBs) | nifedipine | Partially covered | Yes |
Histamine2 receptor blockers (H2 blockers) | cimetidine | Partially covered | Yes |
Histamine2 receptor blockers (H2 blockers) | famotidine | Partially covered | Yes |
Histamine2 receptor blockers (H2 blockers) | nizatidine | Partially covered | Yes |
Histamine2 receptor blockers (H2 blockers) | ranitidine | Fully covered | No |
Non-steroidal anti-inflammatory drugs (NSAIDs)* | diclofenac | Partially covered | Yes |
Non-steroidal anti-inflammatory drugs (NSAIDs)* | ibuprofen | Fully covered | No |
Non-steroidal anti-inflammatory drugs (NSAIDs)* | naproxen | Fully covered | No |
Non-steroidal anti-inflammatory drugs (NSAIDs)* | naproxen EC | Partially covered | Yes |
Non-steroidal anti-inflammatory drugs (NSAIDs)* | naproxen SR | Partially covered | Yes |
Proton pump inhibitors (PPIs) | esomeprazole 20 or 40 mg | Partially covered | Yes |
Proton pump inhibitors (PPIs) | lansoprazole 15 or 30 mg | Partially covered | Yes |
Proton pump inhibitors (PPIs) | omeprazole 20 mg | Partially covered | Yes |
Proton pump inhibitors (PPIs) | pantoprazole magnesium 40 mg | Fully covered | Yes |
Proton pump inhibitors (PPIs) | pantoprazole sodium 40 mg | Partially covered | Yes |
Proton pump inhibitors (PPIs) | rabeprazole 10 and 20 mg | Fully covered | Yes |
Statins | atorvastatin | Fully covered | No |
Statins | fluvastatin | Partially covered | Yes |
Statins | lovastatin | Partially covered | Yes |
Statins | pravastatin | Partially covered | Yes |
Statins | rosuvastatin | Fully covered | No |
Statins | simvastatin | Partially covered | Yes |
* NSAIDs not listed here are not included in the RDP and are Limited Coverage Drugs requiring Special Authority. Please consult the Special Authority drug list for criteria and forms